tradingkey.logo

Conmed Corp

CNMD
40.770USD
+0.600+1.49%
收盤 12/26, 16:00美東報價延遲15分鐘
1.26B總市值
19.71本益比TTM

Conmed Corp

40.770
+0.600+1.49%

關於 Conmed Corp 公司

CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Conmed Corp簡介

公司代碼CNMD
公司名稱Conmed Corp
上市日期Jul 23, 1987
CEOBeyer (Patrick J)
員工數量3900
證券類型Ordinary Share
年結日Jul 23
公司地址11311 Concept Boulevard
城市LARGO
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編33773
電話17272142974
網址https://www.conmed.com/
公司代碼CNMD
上市日期Jul 23, 1987
CEOBeyer (Patrick J)

Conmed Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.13K
+18.20%
Mr. Kim Kelderman
Mr. Kim Kelderman
Independent Director
Independent Director
--
--
Mr. Richard Glaze
Mr. Richard Glaze
Chief Information Officer
Chief Information Officer
--
-100.00%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%
地區USD
名稱
營收
佔比
United States
190.61M
55.68%
Europe & Middle East & Africa
63.92M
18.67%
Asia Pacific
42.07M
12.29%
Americas (excluding the United States)
31.88M
9.31%
業務
地區
業務USD
名稱
營收
佔比
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%

股東統計

更新時間: 11月30日 週日
更新時間: 11月30日 週日
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.90%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.04%
Fuller & Thaler Asset Management Inc.
5.60%
Westwood Management Corp. (Texas)
4.29%
其他
55.53%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.90%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.04%
Fuller & Thaler Asset Management Inc.
5.60%
Westwood Management Corp. (Texas)
4.29%
其他
55.53%
股東類型
持股股東
佔比
Investment Advisor
55.01%
Investment Advisor/Hedge Fund
46.65%
Hedge Fund
7.01%
Research Firm
2.89%
Pension Fund
1.93%
Bank and Trust
0.68%
Individual Investor
0.59%
Sovereign Wealth Fund
0.06%
Insurance Company
0.04%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
638
36.30M
136.51%
+226.00
2025Q3
655
36.31M
137.32%
-1.03M
2025Q2
649
37.27M
138.33%
-832.15K
2025Q1
642
38.16M
137.89%
-4.49M
2024Q4
628
38.56M
133.23%
+1.56M
2024Q3
620
37.00M
134.64%
-1.79M
2024Q2
640
38.79M
129.72%
+1.14M
2024Q1
637
37.49M
133.32%
-3.56M
2023Q4
623
39.15M
131.18%
+747.69K
2023Q3
604
38.42M
132.14%
+127.38K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
4.43M
14.3%
-133.34K
-2.92%
Jun 30, 2025
The Vanguard Group, Inc.
3.54M
11.44%
+42.41K
+1.21%
Jun 30, 2025
EARNEST Partners, LLC
2.83M
9.14%
+30.22K
+1.08%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.74M
5.62%
+566.60K
+48.26%
Jun 30, 2025
Westwood Management Corp. (Texas)
1.24M
4%
-484.00
-0.04%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.08M
3.5%
+184.21K
+20.50%
Jun 30, 2025
State Street Investment Management (US)
1.29M
4.18%
-8.83K
-0.68%
Jun 30, 2025
Managed Account Advisors LLC
1.38M
4.47%
+103.77K
+8.11%
Jun 30, 2025
Silvercrest Asset Management Group LLC
851.95K
2.75%
-183.66K
-17.73%
Jun 30, 2025
Capital Research Global Investors
1.68M
5.41%
+2.76K
+0.16%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
State Street SPDR S&P Health Care Equipment ETF
1.48%
ROBO Global Healthcare Technology & Innovation ETF
1.05%
Invesco S&P SmallCap Health Care ETF
0.83%
Harbor Human Capital Factor US Small Cap ETF
0.56%
First Trust Small Cap Value AlphaDEX Fund
0.49%
VictoryShares Small Cap Free Cash Flow ETF
0.36%
WisdomTree US SmallCap Quality Dividend Growth
0.24%
First Trust Small Cap Core Alphadex Fund
0.24%
Lattice Hartford Multifactor Small Cap ETF
0.23%
Franklin US Small Cap Multifactor Index ETF
0.2%
查看更多
State Street SPDR S&P Health Care Equipment ETF
佔比1.48%
ROBO Global Healthcare Technology & Innovation ETF
佔比1.05%
Invesco S&P SmallCap Health Care ETF
佔比0.83%
Harbor Human Capital Factor US Small Cap ETF
佔比0.56%
First Trust Small Cap Value AlphaDEX Fund
佔比0.49%
VictoryShares Small Cap Free Cash Flow ETF
佔比0.36%
WisdomTree US SmallCap Quality Dividend Growth
佔比0.24%
First Trust Small Cap Core Alphadex Fund
佔比0.24%
Lattice Hartford Multifactor Small Cap ETF
佔比0.23%
Franklin US Small Cap Multifactor Index ETF
佔比0.2%

分紅派息

近5年累計派現 119.19M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Aug 08, 2025
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 03, 2025 going ex on Sep 15, 2025
Sep 15, 2025
Oct 03, 2025
Sep 15, 2025
May 21, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 03, 2025 going ex on Jun 13, 2025
Jun 13, 2025
Jul 03, 2025
Jun 13, 2025
Feb 25, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 04, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 04, 2025
Mar 14, 2025
Dec 10, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 03, 2025 going ex on Dec 20, 2024
Dec 20, 2024
Jan 03, 2025
Dec 20, 2024
Aug 09, 2024
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 04, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 04, 2024
Sep 16, 2024
May 22, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 26, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Dec 05, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2024 going ex on Dec 15, 2023
Dec 18, 2023
Jan 05, 2024
Dec 15, 2023
Aug 10, 2023
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 05, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 05, 2023
Sep 14, 2023
May 24, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 05, 2023
Jun 14, 2023
查看更多

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Conmed Corp的前五大股東是誰?

Conmed Corp的前五大股東如下:
BlackRock Institutional Trust Company, N.A.
持有股份:4.43M
佔總股份比例:14.30%。
The Vanguard Group, Inc.
持有股份:3.54M
佔總股份比例:11.44%。
EARNEST Partners, LLC
持有股份:2.83M
佔總股份比例:9.14%。
Fuller & Thaler Asset Management Inc.
持有股份:1.74M
佔總股份比例:5.62%。
Westwood Management Corp. (Texas)
持有股份:1.24M
佔總股份比例:4.00%。

Conmed Corp的前三大股東類型是什麼?

Conmed Corp 的前三大股東類型分別是:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
EARNEST Partners, LLC

有多少機構持有Conmed Corp(CNMD)的股份?

截至2025Q4,共有638家機構持有Conmed Corp的股份,合計持有的股份價值約為36.30M,占公司總股份的136.51% 。與2025Q3相比,機構持股有所增加,增幅為-0.81%。

哪個業務部門對Conmed Corp的收入貢獻最大?

在FY2025Q2,General Surgery業務部門對Conmed Corp的收入貢獻最大,創收201.61M,占總收入的58.89% 。
KeyAI